chr3-148996317-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004130.4(GYG1):​c.159A>G​(p.Thr53Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,610,978 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0076 ( 11 hom., cov: 32)
Exomes 𝑓: 0.012 ( 147 hom. )

Consequence

GYG1
NM_004130.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.533

Publications

4 publications found
Variant links:
Genes affected
GYG1 (HGNC:4699): (glycogenin 1) This gene encodes a member of the glycogenin family. Glycogenin is a glycosyltransferase that catalyzes the formation of a short glucose polymer from uridine diphosphate glucose in an autoglucosylation reaction. This reaction is followed by elongation and branching of the polymer, catalyzed by glycogen synthase and branching enzyme, to form glycogen. This gene is expressed in muscle and other tissues. Mutations in this gene result in glycogen storage disease XV. This gene has pseudogenes on chromosomes 1, 8 and 13 respectively. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Sep 2010]
GYG1 Gene-Disease associations (from GenCC):
  • polyglucosan body myopathy type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, PanelApp Australia, ClinGen
  • glycogen storage disease XV
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-148996317-A-G is Benign according to our data. Variant chr3-148996317-A-G is described in ClinVar as Benign. ClinVar VariationId is 380453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.533 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00763 (1162/152364) while in subpopulation NFE AF = 0.0129 (879/68034). AF 95% confidence interval is 0.0122. There are 11 homozygotes in GnomAd4. There are 515 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYG1NM_004130.4 linkc.159A>G p.Thr53Thr synonymous_variant Exon 3 of 8 ENST00000345003.9 NP_004121.2
GYG1NM_001184720.2 linkc.159A>G p.Thr53Thr synonymous_variant Exon 3 of 7 NP_001171649.1
GYG1NM_001184721.2 linkc.159A>G p.Thr53Thr synonymous_variant Exon 3 of 6 NP_001171650.1
GYG1XM_017006275.2 linkc.-19A>G 5_prime_UTR_variant Exon 2 of 6 XP_016861764.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYG1ENST00000345003.9 linkc.159A>G p.Thr53Thr synonymous_variant Exon 3 of 8 1 NM_004130.4 ENSP00000340736.4

Frequencies

GnomAD3 genomes
AF:
0.00763
AC:
1162
AN:
152246
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00778
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00320
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0129
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00723
AC:
1817
AN:
251224
AF XY:
0.00683
show subpopulations
Gnomad AFR exome
AF:
0.00277
Gnomad AMR exome
AF:
0.00520
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00434
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.00766
GnomAD4 exome
AF:
0.0121
AC:
17690
AN:
1458614
Hom.:
147
Cov.:
31
AF XY:
0.0118
AC XY:
8562
AN XY:
725684
show subpopulations
African (AFR)
AF:
0.00207
AC:
69
AN:
33382
American (AMR)
AF:
0.00559
AC:
250
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
77
AN:
26128
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39696
South Asian (SAS)
AF:
0.0000929
AC:
8
AN:
86142
European-Finnish (FIN)
AF:
0.00470
AC:
251
AN:
53420
Middle Eastern (MID)
AF:
0.000238
AC:
1
AN:
4204
European-Non Finnish (NFE)
AF:
0.0148
AC:
16417
AN:
1110748
Other (OTH)
AF:
0.0102
AC:
613
AN:
60176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
754
1508
2261
3015
3769
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00763
AC:
1162
AN:
152364
Hom.:
11
Cov.:
32
AF XY:
0.00691
AC XY:
515
AN XY:
74526
show subpopulations
African (AFR)
AF:
0.00240
AC:
100
AN:
41586
American (AMR)
AF:
0.00777
AC:
119
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00320
AC:
34
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0129
AC:
879
AN:
68034
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
59
118
176
235
294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00956
Hom.:
6
Bravo
AF:
0.00787
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0108
EpiControl
AF:
0.0117

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GYG1: BP4, BP7, BS1, BS2

Jun 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Dec 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Glycogen storage disease XV;C4015452:Polyglucosan body myopathy type 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.3
DANN
Benign
0.70
PhyloP100
-0.53
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148619511; hg19: chr3-148714104; API